According to Figure 7A, the expression of Bcl-2 was up-regulated along with the dose increase of SPN, which could maintain the survival and proliferation of erythroid progenitor cells when GATA-1 was reduced in the model of anemia (Figure 3F) (Kapur and Zhang, 2001). The gene discussed is GATA1; the disease is anemia.